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Among the effector functions exhibited  by immunoglobulins is the ability to bind 
to Fc receptors on macrophages, lymphocytes, and granulocytes (1-10). It has recently 
become evident that there are different types of Fc receptors on different types of cells 
(11) and, moreover, that the same cell may express more than one type of Fc receptor 
(1,  2,  5).  For example,  mouse  macrophage  Fc receptors  do not  bind  IgM, whereas 
some lymphocyte Fc receptors  do  (7).  Mouse macrophages  are known to express at 
least  two different  Fc receptors,  one specifically binding mouse IgGt and  IgG2b, the 
other binding  IgG2a (12,  13).  The  Fc receptors  are  distinguishable  by certain  other 
properties  as  well.  The  IgG2a receptor  is  sensitive  to  trypsin  and  shows  decreased 
binding  at  4°C  and  in  the  presence  of cytochalasin  B;  the  IgGl-IgGzb receptor  is 
trypsin resistant and unaltered at 4°C by cytochalasin B  (1,  13). 
The IgGa class of mouse immunoglobulins  has  not  been studied  extensively with 
respect  to its binding  to Fc receptors.  IgGs has  an  Fc fragment  that  is serologically 
and structurally different  from IgG1 and IgG2 (14).  Functionally,  it  has been shown 
to have an increased ability to cross the placenta 04). Earlier experiments have shown 
that  monomeric  IgG3 does  not  inhibit  the  binding  of monomeric  IgG2a  to  its  Fc 
receptor (14). These and other early results have led to the assumption that IgG3 does 
not bind to Fc receptors.  In light of the evidence for multiple  Fc receptors, we felt it 
necessary to examine again the binding of IgGs to Fc receptors. 
We generated a  monoclonal IgGs anti-sheep erythrocyte (SRBC) 1 antibody from a 
mouse spleen-mouse myeloma fusion in order to study directly the binding of IgGa to 
macrophage Fc receptors. Monoclonal antibodies are especially useful in such studies 
because they are homogeneous, they are the only mouse immunoglobulin  in culture 
medium  from  the  hybridoma  cultures,  and  when  reacted  with  their  antigen,  they 
form  antigen-antibody  complexes  more  natural  for  binding  studies  than  artificial 
aggregates.  Using  this  monoclonal  IgG3 anti-SRBC  antibody,  we  found  that  IgG3 
does bind to macrophages through a  third,  independent  IgG Fc receptor. 
Materials  and Methods 
Cells.  J774  is  a  reticulum  cell  sarcoma  from  a  BALB/c  mouse  with  macrophagelike 
properties that has been adapted to culture 05). J774.2 is a clone from the tissue culture line. 
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A series of subclones ofJ774.2 were picked and screened for their ability to bind IgGs. J774.2.1 
was  found  to  lack IgGs receptors.  It  has  grown  to  mass culture  and  recloned  to  produce 
J774.2.1.4.  P388D1  is a  macrophagelike cell line with  Fc receptors and  phagocytic ability. 
FCI.4 and FC1.6 are subclones of the FC1 cell line which arose during a  fusion of MPC  11 
myeloma ceils to spleen cells from a BALB/e mouse immunized with SRBC. FC 1.4 and FC 1.6 
were selected for their inability to phagocytize IgG~-SRBC. 
Primary macrophages were obtained from resident peritoneal cells and from peritoneal cells 
4 d after an intraperitoneal injection of thioglycolate broth (Difco Laboratories, Detroit, Mich.). 
The method for isolating adherent cells has been described previously (1). 
Myeloma Proteins.  Myeloma  proteins  were  obtained  by  injecting  107  MOPC21  (IgGa), 
MPCll  (IgG~b), MOPC173  (IgG2a), or J606 (IgGa) cells into the peritoneal cavity of pristine- 
primed BALB/c mice (16). The aseites fluid was precipitated with 50% saturated ammonium 
sulfate. A  purified -/-globulin fraction was obtained by DEAE  chromatography  (1).  It was 
determined by agarose gel electrophoresis and by Ouchterlony analysis that no fraction had 
any  contaminating  protein  of another  subclass.  Flope  21  was  purchased  from  Bionetics, 
Kensington, Md. Monomeric protein was prepared by centrifuging the protein for 30 min at 
150,000 g. 
Preparation ofIg-coated  SRBC.  The  methods of Bianco et  al.  (17)  were used.  SRBC  were 
incubated with antibody for 30 min at 37°C, washed, and resuspended to 0.5%. The antibodies 
were obtained from cloned hybridoma lines making anti-SRBC antibody, 5 #1 of ascites fluid 
was incubated with 1 ml of a 5% solution of SRBC. 
The IgGs-producing line was derived from a fusion of drug-marked P3 cells with spleen cells 
from a  BALB/c mouse immunized with SRBC.  Segregants no longer making the myeloma 
IgG1 heavy chain were selected. The  IgGz antibody was identified by Ouchterlony analysis 
with commercial anti-IgG3 (Meioy Laboratories, Inc., Springfield, Va.)  and with antiserum 
raised in the laboratory of Dr. John Cebra, University of Pennsylvania, against J606 protein 
and absorbed with IgGa, Ig~a, and IgG2b. 
Fc Rosettes and Fc-mediated Phagocytosis.  This was  done  as  previously described (1).  Cells 
adhered to glass coverslips were incubated for 30 min at 37 ° or 4°C, washed, and assayed for 
rosettes. Attachment of three or more SRBC signified a rosette. For phagoeytosis, the cells were 
incubated for 1 h at 37°C, free SRBC were lysed in hypotonic solution, and intracellular SRBC 
were assayed. A phagocytic cell was any cell with three or more ingested SRBC. Controls were 
run with SRBC incubated in normal mouse serum, and <5% of cells rosetted or phagocytized. 
To study the effect of trypsin and cytochalasin, macrophages were incubated in  1 mg/ml of 
crystallized trypsin in phosphate-buffered saline (PBS), or 10 pg/ml of eytochalasin B (Aldrich 
Chemical Co., Inc., Milwaukee, Wis.) in  PBS for 30  rain at  37°C,  washed, and assayed for 
rosetting ability. 
Inhibition of Binding by Myeloma Proteins. MPCll (IgG2b), MOPC173 (IgG~), MOPC21  (IgGl), 
J606  (IgGs), or Flopc 21  (IgGs) protein was aggregated with bis-diazotized benzidine (BDB) 
(18).  Macrophages were pretreated for 5 rain with the myeloma protein in PBS and then Ig- 
SRBC were added. Rosettes were assayed at 20 rain. 
Inhibitwn of Binding by Protein A.  20 ffl of a 5% solution of SRBC were incubated with 50/~1 
of protein A at 5 mg/ml and 200 ffl of either IgGx, IgG~, IgG2b, or IgGz anti-SRBC antibody. 
The titer of the anti-SRBC antibody in each case was  1:500 using indirect hemagglutination 
with an anti-x antibody. The SRBC were washed and assayed for rosette formation. 
Results 
IgGa-coated SRBC formed rosettes with primary resident and thioglycolate-induced 
peritoneal macrophages, and with J774.2  and P388DI  cell lines (Table I). 
In competitive inhibition experiments (Tables I  and II), aggregates of IgG1, IgG2a, 
and IgG2b all failed to inhibit rosetting of IgGs-coated SRBC,  suggesting a  separate 
receptor for IgGa. In contrast,  two  IgGa myeloma proteins,  Flopc 21  and J606,  did 
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TABLE  I 
Competition with Other IgG Subdasses for Fc Rosetting 
Primary  Primary 
Inhibitor  J774.2  P388DI  resident  TG induced 
IgGa-SRBC  --  97  93  87  89 
IgGl aggregated  96  93  89  89 
IgG2a aggregated  97  91  85  9 l 
IgG2b aggregated  98  91  86  84 
IgG3 aggregated  21  22  19  22 
TABLE II 
Rosettmg of IgGa-SRBC to Macrophages 
Inhibitor* 
Primary  Primary 
J774.2  P388D  1  J774.2.1.4  resident  TG in- 
duced 
IgGa-SRBC  --  98  98  2  87  93 
J606 aggregated  17  21  2  17  21 
Flopc 21 aggregated  19  20  4  22  19 
Flopc monomer  95  91  3  84  97 
* Inhibiting proteins were used at a concentration of 100/~g/ml. 
TABLE III 
Protein A Inhibition of Fc-mediated Rosettes 
J774.2 
IgGa alone  98 
IgGa + protein A  21 
IgGl alone  97 
IgGj + protein A  88 
IgG~ alone  99 
IgG2,, + protein A  18 
IgG2b alone  99 
IgG2b + protein A  21 
IgG3 antibody is binding to the macrophage through its Fc terminal. Monomeric IgG3 
did not inhibit rosetting. 
The  rosetting  of IgG3-SRBC  was  unaffected  at  4°C,  by  cytochalasin  B,  or  by 
trypsinization of the macrophages. In this respect, the IgGa receptor behaves like the 
receptor for IgG1 and IgG2b and unlike the receptor for IgG2a, which is altered at 4°C, 
and by both cytochalasin and trypsin. 
Although inhibition of rosetting by aggregated IgGa suggested that the binding of 
antibody-coated SRBC  was  Fc mediated,  we wanted  to  show  by a  second  method 
that IgGa was bound to receptors on macrophages through its Fc portion. We therefore 
examined whether protein A could inhibit the binding of IgGa. Protein A will bind to 
the Fc portion of several immunoglobulins, including IgG3 and IgG2. It binds poorly 
to IgG1 (19). It has been further shown that protein A  will compete with Fc receptors 
for  Fc  binding  (20).  When  protein  A  was  incubated  with  IgG3-coated  SRBC,  it 
inhibited  rosette  formation.  As expected,  it  also  inhibited  rosetting of IgG2-coated 
SRBC and not of IgGrcoated SRBC  (Table III). 
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TABLE  IV 
Phagocytosis of lgG-SRBC 
Primary 
J774.2  P388D1  J774.2.1.1  Primary  TG in- 
resident  duced 
IgGa  89  87  2  83  91 
IgGl  91  90  88  85  89 
IgG2a  93  88  91  91  92 
IgG2b  92  87  94  85  92 
TABLE V 
Phagocytosis by Variant Lines 
FC 1.4  FC 1.6 
IgGl  89  92 
IgG2a  14  16 
IgGab  91  93 
IgG3  90  90 
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at  all.  It did, however, rosette IgGl-, IgG2a-,  and  IgG2b-coated SRBC  in a  manner 
indistinguishable  from  the  parent  cell  line  (Tables  II  and  IV).  These data  again 
suggest that the receptor for IgG3 is independent of the other IgG receptors. 
We have previously reported variants from the FC 1 macrophage cell line that have 
altered  phagocytosis  through  the  IgG~  receptor  (1).  These  variant  lines  with  a 
selective defect in  phagocytosis were both able  to phagocytize IgGa-coated SRBC, 
suggesting again that the IgGa receptor is independent of the IgG2a receptor (Table 
V). 
Discussion 
It has previously been thought that IgG3 does not bind to Fc receptors on mouse 
macrophages.  This  was  based  on  data  showing  the  inability  of IgG3  to  compete 
successfully with IgG2a for Fc binding (14). It has since become clear that macrophages 
possess more than one Fc receptor and that each receptor has a restricted specificity 
(1, 5,  12). Two receptors have been clearly defined: one for IgG1 and IgG2b, and the 
other for IgG2a (4,  13). 
The studies reported here indicate that there is also a separate Fc receptor on mouse 
macrophages for IgG3. This Fc receptor is present on resident peritoneal macrophages 
as well as on thioglycolate-induced macrophages. In addition, the J774.2 cell line and 
the P388Dl cell line exhibit this receptor. This receptor is independent from the two 
previously identified receptors because (a)  the other IgG subclasses do not compete 
with  IgGs  for binding;  (b)  J774.2.1.4,  a  subclone of J774.2,  is  unable  to  bind  or 
phagocytize IgGa complexes but is unaffected in its IgG2~ and IgGa-IgG2b  receptors; 
and,  (c)  variants  of the  FC1  line  that  are  altered  in  their  ability  to  phagocytize 
through the IgG2a receptor have an intact ability to phagocytize IgGa-SRBC. 
The IgGs Fc receptor is similar to the receptor for IgGa and IgG2b in that it is not 
affected at 4°C or by cytochalasin B or trypsin. It resembles the other IgG receptors 
in its ability to mediate phagocytosis. In addition, we have reported that  IgG3 can 
also mediate antibody-dependent cell-mediated cytolysis of SRBC. 518  Fc RECEPTOR ON MOUSE MACROPHAGES BINDING IgGs 
That  IgGs  should  bind  through  a  separate  receptor  is  not  surprising,  because 
structurally and serologically it is the most dissimilar of the I.gG subclasses (14).  The 
identification of this third receptor, however, raises again the question of why several 
independent Fc receptors are present on macrophages. On macrophages, each receptor 
is  capable  of mediating  both  phagocytosis and  antibody-dependent  cell-mediated 
cytolysis (21).  Other cell  types that bear Fc receptors may possess only one or two of 
these receptors in order to restrict  their response to antibody or immune complexes 
(8,  22,  23).  If Fc  receptors  on  other  cell  types  have  the  same  specificity  as  on 
macrophages, perhaps  the  multiplicity of receptors  allows  for antibody-specific re- 
sponsiveness in other cell types. The multiplicity may be a consequence of the amount 
of information that  must  be carried  in  the constant  region of the  immunoglobulin 
molecule;  the  constraints  of subclass  specificity  may  make  separate  Fc  receptors 
necessary. Further studies on both the biologically active sites  of the IgG molecules 
and  the  nature  of Fc  receptors  on  other  cell  types  are  necessary  to  resolve  these 
questions. 
Summary 
Monoclonal antibodies to sheep erythrocytes (SRBC) have proved useful in iden- 
tifying two Fc receptors on mouse macrophages, one for IgG2a, and one for IgG1 and 
IgG2b. We have used monoclonal IgG3 anti-SRBC to identify a  third Fc receptor on 
mouse macrophages which binds IgG3 uniquely. This receptor is present on primary 
resident and thioglycolate-induced peritoneal macrophages and on some macrophage 
cell  lines.  The  binding  of IgGa-coated SRBC  is  inhibited  by  aggregated  but  not 
monomeric IgGa, and not by IgG1,  IgG2., and IgGeb aggregates. It is unaffected by 
treating the macrophages with trypsin or cytochalasin B and occurs at both 4 °  and 
37°C.  IgGs,  like  all  other  IgG  subclasses,  mediates  phagocytosis.  We  have  also 
generated a  variant macrophage line which bears the receptors for IgGa and IgG2b 
and for IgG2,, but not for IgGs. 
We would like to acknowledge the help of Dr. Peter  Ralph in initiating  these studies and in 
giving advice throughout. 
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